Drug Profile
Miconazole extended-release - Vectans Pharma
Alternative Names: BA-001; Loramyc; Miconazole extended-release - Onxeo; Miconazole Lauriad 50mg Bioadhesive Extended-Release Buccal Tablets; Miconazole Lauriad Bioadhesive Buccal Tablets; Miconazole Lauriad®; ORAVI; Oravig; Sitamic; SO-1105Latest Information Update: 06 Dec 2023
Price :
$50
*
At a glance
- Originator BioAlliance Pharma
- Developer SciClone Pharmaceuticals; Sosei Heptares; Vectans Pharma
- Class Antifungals; Imidazoles; Small molecules
- Mechanism of Action Cell membrane modulators; Cholesterol synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Oropharyngeal candidiasis
Most Recent Events
- 04 Dec 2023 m8 Pharmaceuticals has been acquired by Acino
- 27 Dec 2022 Discontinued - Clinical-Phase-Unknown for Oropharyngeal candidiasis in China (Buccal)
- 21 Dec 2020 Galt Pharmaceuticals plans to launch miconazole extended-release in the first quarter of 2021